Farther Finance Advisors LLC Sells 4,636 Shares of Aflac Incorporated (NYSE:AFL)

Farther Finance Advisors LLC reduced its position in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 33.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 9,135 shares of the financial services provider's stock after selling 4,636 shares during the quarter. Farther Finance Advisors LLC's holdings in Aflac were worth $945,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. Whipplewood Advisors LLC purchased a new stake in shares of Aflac in the fourth quarter worth approximately $26,000. Darwin Wealth Management LLC bought a new position in shares of Aflac in the third quarter valued at approximately $34,000. BankPlus Trust Department bought a new position in shares of Aflac in the fourth quarter valued at approximately $34,000. Raelipskie Partnership bought a new position in Aflac during the third quarter valued at $38,000. Finally, OFI Invest Asset Management bought a new position in Aflac during the fourth quarter valued at $38,000. 67.44% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the sale, the director now owns 25,393 shares in the company, valued at $2,733,048.59. This trade represents a 3.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Audrey B. Tillman sold 24,744 shares of the business's stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the sale, the executive vice president now directly owns 222,618 shares of the company's stock, valued at approximately $23,018,701.20. This trade represents a 10.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 55,546 shares of company stock worth $5,863,616 over the last 90 days. Corporate insiders own 0.80% of the company's stock.

Remove Ads

Aflac Price Performance

Shares of AFL stock traded up $1.13 on Wednesday, reaching $108.49. The company's stock had a trading volume of 1,846,789 shares, compared to its average volume of 1,883,772. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12-month low of $79.31 and a 12-month high of $115.50. The company has a market capitalization of $59.30 billion, a P/E ratio of 11.30, a PEG ratio of 3.24 and a beta of 0.93. The stock's 50 day simple moving average is $105.60 and its 200-day simple moving average is $107.65.

Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing analysts' consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, equities analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

AFL has been the subject of several research reports. Wells Fargo & Company reduced their price objective on Aflac from $104.00 to $102.00 and set an "equal weight" rating for the company in a report on Wednesday, February 19th. Keefe, Bruyette & Woods reduced their price objective on Aflac from $107.00 to $104.00 and set a "market perform" rating for the company in a report on Wednesday, February 12th. Piper Sandler reduced their price objective on Aflac from $122.00 to $118.00 and set an "overweight" rating for the company in a report on Friday, February 7th. StockNews.com raised Aflac from a "sell" rating to a "hold" rating in a report on Friday, February 14th. Finally, Morgan Stanley raised their price target on Aflac from $98.00 to $105.00 and gave the stock an "equal weight" rating in a report on Friday, February 28th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $103.36.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.